您的位置: 首页 > 农业专利 > 详情页

Methods for activating T cells using an inducible chimeric polypeptide
专利权人:
Inc.;Bellicum Pharmaceuticals
发明人:
Foster, Aaron Edward,Spencer, David,Collinson-Pautz, Matthew Robert,Slawin, Kevin
申请号:
AU2015218396
公开号:
AU2015218396A1
申请日:
2015.02.13
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
The technology relates generally to the field of immunology and relates in part to methods for activating cells, including for example T cells and T cells that express chimeric antigen receptors, using an inducible chimeric polypeptide including CD40, MyD88, or CD40 and MyD88 polypeptides. The technology further relates in part to therapeutic methods for inducing an immune response and treating tumors in a patient.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充